Processa Pharmaceuticals, Inc. (PCSA) Total liabilities 2012–2022
Processa Pharmaceuticals, Inc. (PCSA) total liabilities at each fiscal year-end, per SEC filings.
$1.1MFY2022 · since FY2012: $1.3M → $1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $1.1M | +17.4% |
| FY2021 | $978,405 | — |
| FY2016 | $97,692 | -95.3% |
| FY2015 | $2.1M | +55.7% |
| FY2014 | $1.3M | +5.6% |
| FY2013 | $1.3M | -4.1% |
| FY2012 | $1.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice